ArticleJAMA network open2022

Association of Glucagon-Like Peptide-1 Receptor Agonist vs Dipeptidyl Peptidase-4 Inhibitor Use With Mortality Among Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease.

Jia-Jin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.